Add the potential of Parkinson's, Alzheimer and Huntington's disease to the list and we are talking potential blockbuster status. Because of the great safety profile it will lend itself to off label usage and alternative trials without drama. We need a partnership with the big boys because they will be best placed to find every possible angle to use Trofinetide.
Anther thought I had was around spinal injury. If they can get the TBI trial to work, I wonder if it would also have potential to treat spinal cord inflammation post injury. My understanding is that post traumatic inflammation can substantially worsen outcomes.
So if we can get some P2 trials to show all this works the SP might get to 7c!
- Forums
- ASX - By Stock
- NEU
- Below benchmark for 1st month
Below benchmark for 1st month, page-49
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.01 |
Change
-0.010(0.08%) |
Mkt cap ! $1.662B |
Open | High | Low | Value | Volume |
$13.06 | $13.26 | $12.81 | $5.865M | 451.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 14541 | $13.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.02 | 2438 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 14541 | 13.000 |
1 | 75 | 12.990 |
1 | 2500 | 12.960 |
1 | 300 | 12.950 |
4 | 3866 | 12.940 |
Price($) | Vol. | No. |
---|---|---|
13.020 | 2438 | 1 |
13.030 | 867 | 1 |
13.040 | 69 | 1 |
13.050 | 3366 | 3 |
13.070 | 1999 | 1 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online